Aviance Capital Management’s Celgene Corp CELG Stock Holding History

Aviance Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-615	Closed	-$64K	–	323
2017 Q4	$64K	Sell	615 -500	-45%	-$56.4K	﹤0.01%	232
2017 Q3	$163K	Sell	1,115 -106	-9%	-$14.4K	0.01%	182
2017 Q2	$159K	Buy	+1,221	New	+$150K	0.01%	184
2017 Q1	–	Sell	-2,033	Closed	-$235K	–	219
2016 Q4	$235K	Sell	2,033 -220	-10%	-$24.5K	0.01%	180
2016 Q3	$236K	Sell	2,253 -178	-7%	-$19.3K	0.01%	312
2016 Q2	$240K	Buy	2,431 +430	+21%	+$44.5K	0.01%	301
2016 Q1	$200K	Sell	2,001 -2,545	-56%	-$262K	0.01%	290
2015 Q4	$545K	Buy	+4,546	New	+$526K	0.02%	215
2015 Q1	–	Sell	-2,821	Closed	-$316K	–	338
2014 Q4	$316K	Buy	+2,821	New	+$298K	0.01%	263

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Aviance Capital Management's CELG Position: Q1 2018 in Review

Aviance Capital Management sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 615 shares — an estimated $64K sold.

Aviance Capital Management first reported a position in CELG in Q4 2014 and held it in 9 quarters. The position peaked at $545K in Q4 2015. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

Aviance Capital Management reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
Aviance Capital Management sold 615 Celgene Corp shares in Q1 2018, an estimated $64K.
Aviance Capital Management first reported a position in Celgene Corp in Q4 2014 and held it in 9 quarters.
Aviance Capital Management's Celgene Corp position peaked at $545K in Q4 2015.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Aviance Capital Management's 13F filing for Q1 2018, filed 15 May 2018.